Jun 13
|
JPMorgan biotech/pharma analysts hold analyst/industry conference call
|
Jun 13
|
Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?
|
Jun 12
|
PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds
|
Jun 12
|
Novavax's COVID-Flu Combo Shot Shows Strong Immune Response
|
Jun 12
|
Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%
|
Jun 11
|
Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE)
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
Jun 11
|
Pfizer says drugmakers met with Trump admin to discuss lowering drug prices
|
Jun 10
|
Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee
|
Jun 10
|
Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants
|
Jun 10
|
Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.
|
Jun 10
|
Top Cancer Stocks to Supercharge Your 2025 Portfolio
|
Jun 10
|
BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom
|
Jun 10
|
RFK Jr. removes CDC vaccine panel members: What to know
|
Jun 9
|
Pfizer CEO Says No Deals Yet in US Drug Price Talks
|
Jun 9
|
Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip?
|
Jun 9
|
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
|
Jun 9
|
No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says
|
Jun 8
|
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
|
May 30
|
Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%
|